Pune, Dec. 16, 2019 (GLOBE NEWSWIRE) -- The global Exocrine Pancreatic Insufficiency Therapeutics Market to reach USD 2.55 billion by 2026, exhibiting a CAGR of 6.5% during the forecast period. Increasing prevalence of diabetes worldwide is touted to be one of the core factors fueling the growth of this market. According to the International Diabetes Federation (IDF), in 2019, approximately 463 million adults were suffering from diabetes and by 2045, this figure will rise to 700 million. In the same year, the disease caused deaths of 4.2 million people and around 374 million people are at an increased risk of developing type 2 diabetes. Diabetes cause microvascular damage which reduce pancreatic volume, inducing pancreatic fibrosis. According to the National Institutes of Health, those afflicted by type 1 diabetes have a 30 to 50% chance of developing exocrine pancreatic insufficiency, while those with type 2 have a 20 to 30% chance of developing the disorder. Thus, the Exocrine Pancreatic Insufficiency Therapeutics Market stands to gain as a result.
According the new Fortune Business Insights report, titled “Exocrine Pancreatic Insufficiency Therapeutics Market Size, Share & Industry Analysis, By Therapy (Pancreatic Enzyme Replacement Therapy (PERT), Nutritional Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Others) and Regional Forecast, 2019-2026”, the value of the market stood at USD 1.49 billion in 2018. The report also provides an elaborative overview of the general industry trends that will impact the development of the market in the forecast period. Additionally, the report also contains an in-depth analysis of the various factors and dynamics through a thorough research that will aid businesses to formulate strategies to gain traction in this promising market.
For more information in the analysis of this report, visit:
https://www.fortunebusinessinsights.com/industry-reports/exocrine-pancreatic-insufficiency-market-100652
Exocrine Pancreatic Insufficiency (EPI) is a condition that occurs when the pancreas cannot secrete the required amount of digestive juices and enzymes to metabolize food and other nutrients. Symptoms of this condition include flatulence, diarrhea, bloating, and abdominal pain.
Steady Rise in the Incidence of Disorders Associated with EPI to Aid Growth
There are many conditions associated with exocrine pancreatic insufficiency such as celiac disease, cystic fibrosis, inflammatory bowel diseases, and pancreatic cancer. The prevalence of these associated disorders is on the rise, which is expected to ramp up the demand for exocrine pancreatic insufficiency treatment. This increasing demand has led to innovation in EPI medications and therapeutics that have enhanced the potential of this market. One of the most popular development in the market is the creation of the Pancreatic Enzyme Replacement Therapy (PERT) which is furthering the Exocrine Pancreatic Insufficiency Therapeutics Market trends.
Increasing Incidence of Gastrointestinal Disorders to Drive the Market in North America
Among regions, North America is slated to dominate the Exocrine Pancreatic Insufficiency Therapeutics Market share in the forecast period, having generated USD 1.18 billion in 2018 in revenue. The main reasons for this is the increasing prevalence and awareness regarding gastrointestinal diseases in the region along with a high adoption rate of advanced treatment methods for EPI. Rising disposable incomes that have increased the uptake of EPI therapeutics would aid Asia-Pacific register the highest growth rate in this market. Awareness about associated disorders is growing speedily in countries such as Japan and India which will feed the market in the region. In Europe, the market is anticipated to be driven by the increasing penetration of exocrine pancreatic insufficiency medications.
Acquisitions and Regulatory Approvals to Spur Competition
Extensive global presence and strong product offerings are the two prime factors enabling key players in this market to maintain their position. These players are now looking to strengthen their position further through acquisition activities and encouraging regulatory support.
Request a Sample Copy:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/exocrine-pancreatic-insufficiency-market-100652
Key Industry Developments:
- April 2016: Allergan plc received Positive Opinion by the Committee for Medicinal Products for Human Use for the commercial release of ENZEPI, the company’s flagship pancreatic enzyme replacement therapy (PERT) for patients with exocrine pancreatic insufficiency (EPI), in the European Union.
- May 2018: VIVUS, Inc. announced its acquisition of product rights of Janssen Pharmaceuticals’ PANCREAZE, a pancreatic enzyme preparation consisting of pancrelipase, which is an extract derived from porcine pancreatic glands to treat EPI.
List of Key Industry Players Operating in the Exocrine Pancreatic Insufficiency Therapeutics Market Research Report are:
- AzurRx
- AbbVie Inc.
- CHIESI Farmaceutici S.p.A.
- Allergan
- Janssen Pharmaceuticals, Inc.
Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/exocrine-pancreatic-insufficiency-market-100652
Detailed Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Major Disorders Associated with Exocrine Pancreatic Insufficiency
- Pipeline Analysis
- Recent Industry Developments Such as Mergers, Partnerships & Acquisitions
- Regulatory Scenario
- New Product Launches
- Global Exocrine Pancreatic Insufficiency Therapeutics Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Therapy
- Pancreatic Enzyme Replacement Therapy (PERT)
- Creon
- Zenpep
- Others
- Nutritional Therapy
- Pancreatic Enzyme Replacement Therapy (PERT)
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Others
- Market Analysis, Insights and Forecast – By Country
- North America
- Europe
- Asia Pacific
- Rest of the World
TOC Continued….!
Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/exocrine-pancreatic-insufficiency-market-100652
Have a Look at Related Reports:
Orthopedic Joint Replacement Market Size, Share and Global Trend By Product (Knee, Hip, Shoulder, Ankle), By Procedure (Total Replacement, Partial Replacement), By End User (Hospital, Ambulatory Surgical Centers, Orthopedic Clinics) and Geography Forecast till 2026
Next-Generation Sequencing (NGS) Market Size, Share and Global Trend By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Geography Forecast till 2026
Pain Management Devices Market Size, Share and Global Trend By Product Type (Electrical Stimulation Devices, RF Ablation Devices, Neuromodulation Devices, Infusion Pumps), By Application (Musculoskeletal, Brain, Cancer, Neuropathy, Others), By End User (Physiotherapy Centers, Hospitals and Clinics, Others) and Geography Forecast till 2026
Revenue Cycle Management Market Size, Share and Global Trend By Structure (In-house Outsource) By Function (Claims & Denial Management, Medical Coding & Billing, Clinical Documentation Improvement (CDI), Insurance, Others) By Type (Software, Services) and Geography Forecast till 2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1-424-253-0390
UK: +44-2071-939123
APAC: +91-744-740-1245
Email: sales@fortunebusinessinsights.com
Website: Fortune Business Insights™
Follow us on: LinkedIn | Twitter | Blogs